Johnson & Johnson (JNJ) agreed to buy Synthes Inc. (SYST) for $21.3 billion in the biggest purchase of the company’s 125-year history, to become the leader in the $5.5 billion market for devices that treat trauma victims.
INTERIM DIVIDEND
Johnson & Johnson (JNJ) agreed to buy Synthes Inc. (SYST) for $21.3 billion in the biggest purchase of the company’s 125-year history, to become the leader in the $5.5 billion market for devices that treat trauma victims.